Oneness Biotech Financials
4743 Stock | TWD 79.20 0.20 0.25% |
Oneness |
Understanding current and past Oneness Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Oneness Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Oneness Biotech's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Oneness Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Oneness Biotech Co. Check Oneness Biotech's Beneish M Score to see the likelihood of Oneness Biotech's management manipulating its earnings.
Instrument | Taiwan Stock View All |
Exchange | Taiwan OTC Exchange |
ISIN | TW0004743000 |
Business Address | No236, Xinyi Road, |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | www.onenessbio.com |
Phone | 886 2 2703 1098 |
Currency | TWD - New Taiwan Dollar |
You should never invest in Oneness Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Oneness Stock, because this is throwing your money away. Analyzing the key information contained in Oneness Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Oneness Biotech Key Financial Ratios
There are many critical financial ratios that Oneness Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Oneness Biotech reports annually and quarterly.Return On Equity | 0.0788 | |||
Return On Asset | -0.0068 | |||
Number Of Employees | 20 | |||
Beta | 1.65 |
Oneness Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oneness Biotech's current stock value. Our valuation model uses many indicators to compare Oneness Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oneness Biotech competition to find correlations between indicators driving Oneness Biotech's intrinsic value. More Info.Oneness Biotech Co is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oneness Biotech's earnings, one of the primary drivers of an investment's value.Oneness Biotech Systematic Risk
Oneness Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Oneness Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Oneness Biotech correlated with the market. If Beta is less than 0 Oneness Biotech generally moves in the opposite direction as compared to the market. If Oneness Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Oneness Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Oneness Biotech is generally in the same direction as the market. If Beta > 1 Oneness Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Oneness Biotech January 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Oneness Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oneness Biotech Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oneness Biotech Co based on widely used predictive technical indicators. In general, we focus on analyzing Oneness Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oneness Biotech's daily price indicators and compare them against related drivers.
Information Ratio | (0.33) | |||
Maximum Drawdown | 12.88 | |||
Value At Risk | (5.58) | |||
Potential Upside | 2.99 |
Additional Tools for Oneness Stock Analysis
When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.